You are the owner of this page.
Edit Page
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Seattle Genetics Inc (NQ: SGEN)
108.30 USD  -0.04 (-0.04%)
Official Closing Price  /  Updated: 5:26 PM EST, Nov 11, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 620,000
Open 107.80
Bid (Size) 92.05 (1)
Ask (Size) 109.00 (1)
Prev. Close 108.34
Today's Range 106.84 - 108.95
52wk Range 51.50 - 108.95
Shares Outstanding 158,224,428
Dividend Yield N/A
Performance
YTD
+88.38%
+88.38%
1 Month
+31.40%
+31.40%
3 Month
+42.29%
+42.29%
6 Month
+69.48%
+69.48%
1 Year
+96.98%
+96.98%
Top News
More News
Seattle Genetics Announces Multiple ADCETRIS® (Brentuximab Vedotin) Presentations at the ASH Annual Meeting
Seattle Genetics, Inc. (Nasdaq:SGEN) today announced data from its ADCETRIS® (brentuximab vedotin) clinical development program at the 61st American Society of Hematology (ASH) Annual Meeting and... Read More
from Business Wire News Releases
Seattle Genetics and BeiGene Announce Global License Agreement for Advanced Preclinical Product Candidate
Seattle Genetics, Inc. (Nasdaq: SGEN) and BeiGene, Ltd. (Nasdaq: BGNE; HKEX: 06160) today announced that the companies have entered into a license agreement for an advanced preclinical product... Read More
from Business Wire News Releases
More News
Read More
Seattle Genetics Responds to Daiichi Sankyo’s Complaint for Declaratory Judgment
from Business Wire News Releases
Seattle Genetics to Present at Credit Suisse 28th Annual Healthcare Conference
from Business Wire News Releases
Seattle Genetics Reports Third Quarter 2019 Financial Results
from Business Wire News Releases
Week in Review: AstraZeneca Announces $1 Billion Fund for China Life Science Startups
from ChinaBio® Today
Here's Why Seattle Genetics Stock Jumped 25.7% in October
category SGEN , Market News
from Motley Fool
BeiGene Enters $160 Million Deal for Rights to Seattle Genetics Cancer Molecule
from ChinaBio® Today
Buy These 2 Stocks to Access China's Huge Healthcare Market
category NVCR , GSK , MRK , and 8 more.
from Motley Fool
Seattle Genetics Inc (SGEN) Q3 2019 Earnings Call Transcript
category Market News , SGEN
from Motley Fool
1 No-Brainer Pharmaceutical Stock to Buy
category Market News , SGEN , CELG , and 2 more.
from Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.